Mild kidney disease, which affects up to a third of the adult population, is linked to an increased risk of developing and dying from cancer, according to a study.
Researchers discovered the link using a “cystatin C” test which they said is more sensitive than the one commonly used by the NHS.
Using data from the UK Biobank alongside the simple blood test, the research, led by the University of Glasgow and published in EClinicalMedicine, found that mild kidney disease is associated with a 4 per cent increased risk of developing cancer and a 15 per cent higher risk of dying from it.
In people with more advanced kidney disease, researchers found a 19 per cent increased risk in developing cancer and a 48 per
